Full text is available at the source.
Abstract
GLP-1 receptor agonists have a moderate effect on weight loss after metabolic and bariatric surgery, with a Cohen's d-score of 0.470.
- Patients may experience insufficient weight loss or weight regain following metabolic and bariatric surgery.
- Glucagon-like peptide-1 receptor agonists are associated with appetite suppression, slowed gastric emptying, and fat loss.
- The pooled analysis indicates that GLP-1 agonists could be effective for addressing weight issues post-surgery.
- Further research is suggested to evaluate the role of GLP-1 agonists as part of standard care for these patients.
Simplified